Daiwa Securities Group Inc. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$10
-23.1%
2820.0%0.00%
Q2 2023$13
+18.2%
2820.0%0.00%
Q1 2023$11
-15.4%
2820.0%0.00%
Q4 2022$13
-99.9%
282
+8.0%
0.00%
Q3 2022$11,000
-31.2%
2610.0%0.00%
Q2 2022$16,000
+14.3%
261
+31.2%
0.00%
Q1 2022$14,000
-17.6%
1990.0%0.00%
Q4 2021$17,000
-19.0%
199
-14.2%
0.00%
Q3 2021$21,000
+61.5%
232
+74.4%
0.00%
Q2 2021$13,000
-13.3%
1330.0%0.00%
Q1 2021$15,000
-11.8%
133
+7.3%
0.00%
Q4 2020$17,000
-39.3%
124
-63.5%
0.00%
Q3 2020$28,000
+100.0%
340
+4.3%
0.00%
Q2 2020$14,0000.0%3260.0%0.00%
Q1 2020$14,0000.0%3260.0%0.00%
Q4 2019$14,000
-6.7%
326
-8.9%
0.00%
Q3 2019$15,000
-34.8%
3580.0%0.00%
Q2 2019$23,000
-8.0%
3580.0%0.00%
Q1 2019$25,000
+127.3%
358
+37.7%
0.00%
Q4 2018$11,000
-45.0%
2600.0%0.00%
Q3 2018$20,0000.0%2600.0%0.00%
Q2 2018$20,000
+53.8%
2600.0%0.00%
Q1 2018$13,0002600.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders